Loading
AP
Avadel Pharmaceuticals PLC Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Palczuk Linda, was filed 22 Jan 2025.
Avadel Pharmaceuticals PLC: what insiders have been doing
Avadel Pharmaceuticals PLC belongs to the Health Care sector. Filings by its managers are published through SEC (Form 4). 10 insiders have disclosed 11 filings since 18 October 2025.
All open-market trades in the period are sales: 1 sale worth €196.6M, by 1 insider, with no purchase on record. Biggest ticket of the year: €196.6M, sold by Weiss Asset Management LP and made public on 18 February 2026.
Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives.
Across the 5,814 companies tracked on its exchange, the median is 19 filings; at 11 filings, this issuer sits below that mark. Over the whole record (from 2022), the tally stands at 27 purchases and 3 sales.
For comparison within the same sector, see the insider buying recorded at Cooper Companies, Inc. and Anixa Biosciences Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
56
Thresholds
n/a
Buy Volume
€2M
27 ops. · all time
Sell Volume
€198M
3 ops. · all time
Who traded when
BuySaleGeoffrey Michael Glass2 buys
Gregory J. Divis2 buys
Linda Palczuk2 buys
Thomas S. Mchugh2 buys
Eric J. Ende1 buy
Peter J. Thornton1 buy
+1 other insider
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2024FY ended December 2024 · cache
Income statement
RevenueUS$146.6M
Gross profitUS$133.4M91% margin
Net income-US$42.3M-28.9% margin
Last declaration on 18 February 2026
Declarations56 total
11,112,052 shares@ US$21.00100.0% of flowOrdinary SharesSEC:0001357550-26-000015:0
78,905 shares@ US$21.0091.5% of flowOrdinary SharesSEC:0001104659-26-014446:0
115,060 shares@ US$21.0092.8% of flowOrdinary SharesSEC:0001104659-26-014448:0
23,496 shares@ US$21.00100.0% of flowOrdinary SharesSEC:0001104659-26-014447:0
100,400 shares@ US$21.0087.1% of flowOrdinary SharesSEC:0001104659-26-014445:0
22,000 shares@ US$21.0022.1% of flowOrdinary SharesSEC:0001104659-26-014444:0
22,005 shares@ US$21.0041.9% of flowOrdinary SharesSEC:0001104659-26-014443:0
219,905 shares@ US$21.0086.4% of flowOrdinary SharesSEC:0001104659-26-014442:0
211,105 shares@ US$21.0092.3% of flowOrdinary SharesSEC:0001104659-26-014441:0
22,000 shares@ US$21.00100.0% of flowOrdinary SharesSEC:0001104659-26-014438:0
67,025 shares0Ordinary SharesSEC:0001104659-26-011511:0
11,000 shares0Ordinary SharesSEC:0001104659-25-072695:0
11,000 shares0Ordinary SharesSEC:0001104659-25-072692:0
11,000 shares0Ordinary SharesSEC:0001104659-25-072687:0
11,000 shares0Ordinary SharesSEC:0001104659-25-072682:0
11,000 shares0Ordinary SharesSEC:0001104659-25-072686:0
11,000 shares0Ordinary SharesSEC:0001104659-25-072685:0
52,000 shares0Ordinary SharesSEC:0001104659-25-021732:0
14,700 shares0Ordinary SharesSEC:0001104659-25-021736:0
12,600 shares0Ordinary SharesSEC:0001104659-25-021733:0
5,000 shares@ US$7.9282.5% of flowOrdinary SharesSEC:0001104659-25-005248:0
Canonical exit: 21 Apr 2025 (T+90)
10,000 shares@ US$8.0453.6% of flowOrdinary SharesSEC:0001104659-25-003452:0
Canonical exit: 13 Apr 2025 (T+90)
30,000 shares@ US$7.84065.1% of flowOrdinary SharesSEC:0001104659-25-003451:0
Canonical exit: 13 Apr 2025 (T+90)
3,500 shares0Ordinary SharesSEC:0001104659-24-132145:0
2,300 shares@ US$10.44291.1% of flowOrdinary SharesSEC:0001104659-24-128666:0
Canonical exit: 13 Mar 2025 (T+90)
25 of 56 declarations
About Avadel Pharmaceuticals PLC
Avadel Pharmaceuticals PLC is a biopharmaceutical company focused on developing innovative treatments for sleep disorders and other diseases. It is listed on NASDAQ under the ticker AVDL.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
